136 related articles for article (PubMed ID: 37449977)
1. AZD7762 induces CRBN dependent BAG3 degradation through ubiquitin-proteasome pathway.
Liao Y; Yuan C; Huang M; Si W; Li D; Wu W; Zhang S; Wu R; Quan Y; Yu X; Liao S
Anticancer Drugs; 2024 Jan; 35(1):46-54. PubMed ID: 37449977
[TBL] [Abstract][Full Text] [Related]
2. BAG3 induces the sequestration of proteasomal clients into cytoplasmic puncta: implications for a proteasome-to-autophagy switch.
Minoia M; Boncoraglio A; Vinet J; Morelli FF; Brunsting JF; Poletti A; Krom S; Reits E; Kampinga HH; Carra S
Autophagy; 2014 Sep; 10(9):1603-21. PubMed ID: 25046115
[TBL] [Abstract][Full Text] [Related]
3. PKM2 compensates for proteasome dysfunction by mediating the formation of the CHIP-HSP70-BAG3 complex and the aggregation of ubiquitinated proteins.
Zhang C; Tang Q; Xia H; Xu H; Bi F
FASEB J; 2022 Jan; 36(1):e22121. PubMed ID: 34951719
[TBL] [Abstract][Full Text] [Related]
4. The anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome.
Virador VM; Davidson B; Czechowicz J; Mai A; Kassis J; Kohn EC
PLoS One; 2009; 4(4):e5136. PubMed ID: 19352495
[TBL] [Abstract][Full Text] [Related]
5. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
[TBL] [Abstract][Full Text] [Related]
6. Exploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology.
Ito T; Yamaguchi Y; Handa H
Cell Chem Biol; 2021 Jul; 28(7):987-999. PubMed ID: 34033753
[TBL] [Abstract][Full Text] [Related]
7. Cereblon-mediated degradation of the amyloid precursor protein via the ubiquitin-proteasome pathway.
Kurihara T; Asahi T; Sawamura N
Biochem Biophys Res Commun; 2020 Mar; 524(1):236-241. PubMed ID: 31983437
[TBL] [Abstract][Full Text] [Related]
8. Development of decoy oligonucleotide-warheaded chimeric molecules targeting STAT3.
Shih PC; Naganuma M; Tsuji G; Demizu Y; Naito M
Bioorg Med Chem; 2023 Nov; 95():117507. PubMed ID: 37922656
[TBL] [Abstract][Full Text] [Related]
9. The stress protein BAG3 stabilizes Mcl-1 protein and promotes survival of cancer cells and resistance to antagonist ABT-737.
Boiani M; Daniel C; Liu X; Hogarty MD; Marnett LJ
J Biol Chem; 2013 Mar; 288(10):6980-90. PubMed ID: 23341456
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel potential CRBN modulators through structure-based virtual screening and bioassay.
Xiong F; Zhou LY; Chen L; Cao F; Zhang S; Zuo Z
J Mol Graph Model; 2022 Dec; 117():108325. PubMed ID: 36088765
[TBL] [Abstract][Full Text] [Related]
11. An unexpected role for BAG3 in regulating PARP1 ubiquitination in oxidative stress-related endothelial damage.
Zhang N; Zhang Y; Miao W; Shi C; Chen Z; Wu B; Zou Y; Ma Q; You S; Lu S; Huang X; Liu J; Xu J; Cao L; Sun Y
Redox Biol; 2022 Apr; 50():102238. PubMed ID: 35066290
[TBL] [Abstract][Full Text] [Related]
12. BAG3 induction is required to mitigate proteotoxicity via selective autophagy following inhibition of constitutive protein degradation pathways.
Rapino F; Jung M; Fulda S
Oncogene; 2014 Mar; 33(13):1713-24. PubMed ID: 23644654
[TBL] [Abstract][Full Text] [Related]
13. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
Ishida T; Ciulli A
SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
[TBL] [Abstract][Full Text] [Related]
14. Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity.
Chen Y; Yang LN; Cheng L; Tu S; Guo SJ; Le HY; Xiong Q; Mo R; Li CY; Jeong JS; Jiang L; Blackshaw S; Bi LJ; Zhu H; Tao SC; Ge F
Mol Cell Proteomics; 2013 Oct; 12(10):2804-19. PubMed ID: 23824909
[TBL] [Abstract][Full Text] [Related]
15. BAG3 down-modulation reduces anaplastic thyroid tumor growth by enhancing proteasome-mediated degradation of BRAF protein.
Chiappetta G; Basile A; Arra C; Califano D; Pasquinelli R; Barbieri A; De Simone V; Rea D; Giudice A; Pezzullo L; De Laurenzi V; Botti G; Losito S; Conforti D; Turco MC
J Clin Endocrinol Metab; 2012 Jan; 97(1):E115-20. PubMed ID: 22072743
[TBL] [Abstract][Full Text] [Related]
16. Chemical approaches to targeted protein degradation through modulation of the ubiquitin-proteasome pathway.
Collins I; Wang H; Caldwell JJ; Chopra R
Biochem J; 2017 Mar; 474(7):1127-1147. PubMed ID: 28298557
[TBL] [Abstract][Full Text] [Related]
17. BAG3-dependent noncanonical autophagy induced by proteasome inhibition in HepG2 cells.
Liu BQ; Du ZX; Zong ZH; Li C; Li N; Zhang Q; Kong DH; Wang HQ
Autophagy; 2013 Jun; 9(6):905-16. PubMed ID: 23575457
[TBL] [Abstract][Full Text] [Related]
18. Combination of artesunate and WNT974 induces KRAS protein degradation by upregulating E3 ligase ANACP2 and β-TrCP in the ubiquitin-proteasome pathway.
Gong RH; Chen M; Huang C; Wong HLX; Kwan HY; Bian Z
Cell Commun Signal; 2022 Mar; 20(1):34. PubMed ID: 35305671
[TBL] [Abstract][Full Text] [Related]
19. Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway.
Hirose Y; Kitazono T; Sezaki M; Abe M; Sakimura K; Funato H; Handa H; Vogt KE; Yanagisawa M
Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23106-23112. PubMed ID: 32848052
[TBL] [Abstract][Full Text] [Related]
20. Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4(CRBN.).
Gandhi AK; Kang J; Havens CG; Conklin T; Ning Y; Wu L; Ito T; Ando H; Waldman MF; Thakurta A; Klippel A; Handa H; Daniel TO; Schafer PH; Chopra R
Br J Haematol; 2014 Mar; 164(6):811-21. PubMed ID: 24328678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
